Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Ali

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Addiction (Abingdon, England)|April 15, 2020
Global opioid agonist treatment: a review of clinical practices by countryHarry Jin, Brandon D L Marshall, Louisa Degenhardt, et al.
BMJ Open|August 8, 2018
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) StudySarah Larney, Matthew Hickman, David A Fiellin, et al.
Addiction (Abingdon, England)|May 9, 2012
Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)Rebecca McKetin, Jake M Najman, Amanda L Baker, et al.
Drug and Alcohol Dependence|September 11, 2020
The contribution of methamphetamine use to crime: Evidence from Australian longitudinal dataRebecca McKetin, Joseph M Boden, James A Foulds, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
Substance Abuse|November 2, 2010
United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: TreatnetJuana Tomás-Rosselló, Richard A Rawson, Maria J Zarza, et al.
Journal of Gastrointestinal Oncology|January 18, 2020
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancerSofia Palacio, Hannah S McMurry, Robert Ali, et al.
Child and Adolescent Psychiatry and Mental Health|January 13, 2025
Validity, reliability and clinical utility of ASSIST-Y in assessing risk of substance-related harm and dependence in Spanish male adolescentsNúria Ibáñez-Martínez, Matthew William Richard Stevens, Núria Civit-Bel, et al.
Addiction (Abingdon, England)|December 21, 2019
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in AustraliaBriony Larance, Louisa Degenhardt, Jason Grebely, et al.
Drug and Alcohol Dependence|April 16, 2014
Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT)John Marsden, Brian Eastwood, Robert Ali, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Addiction (Abingdon, England)|April 15, 2020
Global opioid agonist treatment: a review of clinical practices by countryHarry Jin, Brandon D L Marshall, Louisa Degenhardt, et al.
BMJ Open|August 8, 2018
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) StudySarah Larney, Matthew Hickman, David A Fiellin, et al.
Addiction (Abingdon, England)|May 9, 2012
Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)Rebecca McKetin, Jake M Najman, Amanda L Baker, et al.
Drug and Alcohol Dependence|September 11, 2020
The contribution of methamphetamine use to crime: Evidence from Australian longitudinal dataRebecca McKetin, Joseph M Boden, James A Foulds, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
Substance Abuse|November 2, 2010
United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: TreatnetJuana Tomás-Rosselló, Richard A Rawson, Maria J Zarza, et al.
Journal of Gastrointestinal Oncology|January 18, 2020
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancerSofia Palacio, Hannah S McMurry, Robert Ali, et al.
Child and Adolescent Psychiatry and Mental Health|January 13, 2025
Validity, reliability and clinical utility of ASSIST-Y in assessing risk of substance-related harm and dependence in Spanish male adolescentsNúria Ibáñez-Martínez, Matthew William Richard Stevens, Núria Civit-Bel, et al.
Addiction (Abingdon, England)|December 21, 2019
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in AustraliaBriony Larance, Louisa Degenhardt, Jason Grebely, et al.
Drug and Alcohol Dependence|April 16, 2014
Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT)John Marsden, Brian Eastwood, Robert Ali, et al.
Pageof 12